HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

abyssinone II

chemopreventive agent from Broussonetia papypera; structure in first source

Also Known As:

7-hydroxy-2-(4-hydroxy-3-(methyl-but-2-enyl)phenyl)chroman-4-one

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        abyssinone II: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        abyssinone II: 2

Experts

1.	Halder, Sajal Kumar: 1 article (01/2021)
2.	Hasan, Md Ashraful: 1 article (01/2021)
3.	Shawan, Mohammad Mahfuz Ali Khan: 1 article (01/2021)
4.	Croy, Vicki L: 1 article (06/2007)
5.	Cuendet, Muriel: 1 article (06/2007)
6.	Cushman, Mark: 1 article (06/2007)
7.	Endringer, Denise C: 1 article (06/2007)
8.	Maiti, Arup: 1 article (06/2007)
9.	Pezzuto, John M: 1 article (06/2007)

Related Diseases

1.	COVID-19 01/01/2021 - "Conclusively, the current study proposes that luteolin and abyssinone II might act as potential therapeutic candidates for SARS-CoV-2 infection. " 01/01/2021 - "Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak."
2.	Breast Neoplasms (Breast Cancer) 06/14/2007 - "Synthesis and biological evaluation of (+/-)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer."

Related Drugs and Biologics

1.	Luteolin
2.	Aromatase Inhibitors

Related Therapies and Procedures

1.	Chemoprevention